0HIY.LAtara Biotherapeutics Inc

About

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

www.atarabio.com

Key Statistics

Market Cap

102.37M

EPS

2.61

Dividend Yield

0.00%

Beta

0.11

P/B

-5.86

Return on Equity

-84.9%

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Anhco Nguyen

Employees

14

IPO Date

2018-01-29

Country

US